Header cover image

Investing Ideas
/
Swedish Pharmaceuticals & Biotech Pure Equity Growth

Swedish Pharmaceuticals & Biotech Pure Equity Growth

Results

6

0 new

Companies that has zero debt on their balance sheet and is forecast to grow at an exponential rate in the future.

6 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	CAMX Camurus	SEK 648.00	-2.7%	110.4%	SEK 38.1b	SEK 742.67	PE170.6x	E75.0%	n/a
	BONEX Bonesupport Holding	SEK 310.00	2.2%	146.6%	SEK 20.4b	SEK 323.33	PE70.6x	E31.2%	n/a
	BIOA B BioArctic	SEK 163.30	-4.6%	-41.7%	SEK 14.4b	SEK 290.60	PS48.2x	E98.4%	0%
	BIOVIC B Biovica International	SEK 2.57	-1.7%	-64.6%	SEK 231.7m	SEK 6.20	PS32x	E78.5%	n/a
	NEWBRY Newbury Pharmaceuticals	SEK 3.30	11.5%	-8.1%	SEK 80.1m	SEK 8.00	PS4.3x	E116.2%	n/a
	SCOL Scandion Oncology	SEK 0.15	4.2%	-90.2%	SEK 34.8m	n/a	PB0.7x	E75.3%	n/a

Page 1 of 1